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Under ‘‘permissive’’ conditions at 25 C, the chaperonin substrate protein DM-MBP refolds 5–10
times more rapidly in the GroEL/GroES folding chamber than in free solution. This has been sug-
gested to indicate that the chaperonin accelerates polypeptide folding by entropic effects of close
conﬁnement. Here, using native-puriﬁed DM-MBP, we show that the different rates of refolding
are due to reversible aggregation of DM-MBP while folding free in solution, slowing its kinetics of
renaturation: the protein exhibited concentration-dependent refolding in solution, with aggrega-
tion directly observed by dynamic light scattering. When refolded in chloride-free buffer, however,
dynamic light scattering was eliminated, refolding became concentration-independent, and the rate
of refolding became the same as that in GroEL/GroES. The GroEL/GroES chamber thus appears to
function passively toward DM-MBP.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The GroES-encapsulated ring of the chaperonin GroEL provides
a folding chamber that is essential for proper folding of many poly-
peptide substrates under what are called ‘‘non-permissive condi-
tions’’, where there is relatively high substrate protein
concentration and elevated temperature, resembling physiologic
conditions [1–4]. Under such conditions, polypeptide substrates
cannot reach the native state in free solution, being subject to
wholesale aggregation. Yet under conditions of reduced substrate
concentration and lower temperature, so-called ‘‘permissive’’ con-
ditions which disfavor aggregation in free solution, many of these
proteins can reach the native form either inside the chaperonin
chamber or free in solution [2,5,6]. In some cases under permissive
conditions, the rate of folding to native form by the chaperonin
system is many fold greater than in free solution [5,7]. This has
been suggested to reﬂect an ability of the chaperonin chamber to
intrinsically accelerate the rate of folding of encapsulated substrate
proteins, e.g., by entropic effects of close conﬁnement [7,8]. On thechemical Societies. Published by E
e binding protein
al Institute, Yale University,
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wich).other hand, certain experiments have shown that the difference in
rates is due to reversible off-pathway steps of aggregation of sub-
strate proteins attempting to fold in free solution [9].
A substrate for which considerable testing has been carried out
under permissive conditions is a secretion signal-deleted (cyto-
solic) double mutant form of maltose binding protein (DM-MBP;
V8G/Y283D; 41 kDa; e.g., Refs. [7–9]). Most recently, it has been re-
ported that this protein, expressed at low temperature in Esche-
richia coli and puriﬁed in native form using amylose afﬁnity
resin, exhibited no evidence of aggregation in free solution follow-
ing its dilution from guanidine–HCl [8]. This is in contrast to earlier
studies observing aggregation of inclusion body-puriﬁed DM-MBP
after dilution from guanidine–HCl into free solution [9]. Here we
report refolding studies using low temperature-expressed, na-
tive-puriﬁed, DM-MBP, as in Ref. [8].
2. Materials and methods
2.1. Proteins
GroEL and GroES were expressed and puriﬁed as described in
Rye et al [10]. The mature forms of wild-type MBP and DM-MBP
(V8G/Y283D) were expressed as soluble proteins in E. coli grown
at 25 C and puriﬁed on amylose resin (New England Biolabs) as
described previously [7,8].lsevier B.V. All rights reserved.
Fig. 1. Folding rates and light scattering behavior of DM-MBP and wt-MBP. (a) Rate of refolding of wt-MBP following dilution from guanidine–HCl as a function of ﬁnal
concentration of DM-MBP in the buffer. Tryptophan ﬂuorescence was monitored and the single exponential rise in ﬂuorescence was ﬁt as described in Methods to derive the
respective rate constants. There is no appreciable effect of concentration across the range of 25 nM to 1 lM wt-MBP. Error bars represent the standard deviations (n = 3). (b)
Rate of refolding of DM-MBP following dilution from guanidine–HCl denaturant as a function of ﬁnal concentration of DM-MBP in the buffer. Rates were determined as
described in (a) (n = 3). The line is illustrative only. There is a 3-fold fall in rate across the same range as tested in (a). (c) Rate of refolding of DM-MBP diluted from urea into
chloride-free buffer (see Section 2.2) as a function of ﬁnal concentration of DM-MBP in the buffer. The same concentration range was tested as in (a) and (b) (n = 3). There is a
minimal effect of concentration on the rate of refolding (10% decrease). (d) Dynamic light scattering, in arbitrary units, during refolding of 250 nM DM-MBP in solution, DM-
MBP (+Cl). In contrast, DM-MBP refolding in chloride-free solution did not produce signiﬁcant light scattering, DM-MBP (Cl). Inset, for comparison, shows light scattering
when both DM-MBP and wt-MBP are in chloride-containing buffer. Raw light-scattering intensity data, in arbitrary units, is plotted vs time. (e) Rate of GroEL–GroES–ATP
mediated refolding of DM-MBP as a function of concentration of DM-MBP following dilution from guanidine–HCl into buffer containing GroEL, where a binary complex of
DM-MBP/GroEL is formed. GroES and ATP were then added and the refolding of DM-MBP monitored by tryptophan ﬂuorescence (note that GroEL and GroES are devoid of
tryptophan). The rate constants were determined as for the protein refolding in free solution (n = 3). No appreciable concentration dependence was observed, and the rate
corresponded closely to that for DM-MBP refolding in chloride-free buffer (compare with panel c).
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For refolding free in solution containing chloride, DM-MBP or
wild-type MBP was diluted 100-fold from a solution containing
6 M guanidine–HCl, 100 mM Tris–HCl (pH 7.5), 20 mM KCl, into
buffer containing 20 mM Tris–HCl (pH 7.5), 200 mM KCl,
5 mMMg(OAc)2 at 25 C. For refolding under chloride-free condi-
tions, DM-MBP was diluted from a 9.5 M urea solution into buffer
containing 100 mM Hepes (pH 7.5), 20 mM KOAc, 5 mMMg(OAc)2.
For chaperonin-mediated refolding, DM-MBP unfolded in 6 M gua-
nidine–HCl or 9.5 M urea was diluted 100-fold into buffer with or
without chloride, respectively, containing a 2.5-fold molar excess
of GroEL over the ﬁnal DM-MBP concentration to form binary com-
plexes. GroES in a two-fold molar excess to GroEL and 5 mM ATP
were subsequently added to commence folding.
2.3. Assays
Refolding of MBP and DM-MBP was followed by an increase of
tryptophan ﬂuorescence (excitation, 295 nm; emission, 345 nm)
using a PTI QuantaMaster ﬂuorescence spectrometer. Rates of
refolding of MBP were determined by ﬁtting the change in ﬂuores-
cence to a single exponential equation using Origin. Results from at
least three separate experiments were averaged for each data
point. Light scattering experiments were carried out on a DynaPro
dynamic light scattering instrument (Wyatt Technology; 830 nm
light, 90 scattering angle), using buffer conditions identical to
those used for refolding.
3. Results and discussion
Concern about the purity of the inclusion body-isolated DM-
MBP used in our previous experiments relative to the native-iso-
lated DM-MBP employed in the recently reported experiments
[8] led us to compare the renaturation of the two preparations
in free solution. We observed that, at 1 lM protein concentra-
tion, the inclusion body preparation of DM-MBP refolded more
slowly, at 50% the rate of the native-isolated DM-MBP. It
seemed likely that the slower refolding of the inclusion body-
prepared protein was due to contaminants, although no major
protein contaminants were apparent in SDS gel analysis (Suppl.
Fig. 1) or in gel ﬁltration analysis. In addition, Q-Tof MS analyses
of the two protein preparations were identical (not shown). Nev-
ertheless we worried that lipid or carbohydrate contamination,
not detectable with these analytical methods, might be involved.
Therefore, we further puriﬁed the inclusion body material via
anion exchange chromatography in urea, followed by dialysis/
renaturation. The rate of refolding of this puriﬁed material at
1 lM after dilution from guanidine–HCl was identical to that
of the native-isolated DM-MBP (not shown). For ease of compar-
ison, however, in all subsequent experiments we employed na-
tive-isolated material prepared exactly as described by
Chakraborty et al. [8].
First we compared the rate of refolding of native-isolated wild-
type MBP diluted from guanidine–HCl denaturant with that of
identically treated native-isolated DM-MBP. The rate of refolding
of the wild-type protein was approximately 50-fold greater than
that of the mutant protein (Fig. 1, compare panels a and b), in
agreement with earlier studies. Whereas the rate of refolding of
the wild-type protein did not exhibit a concentration dependence
across the range of 25 nM to 1 lM, the rate for the mutant protein
exhibited a concentration-dependent decrease of approximately 3-
fold across this range, with a steeper decrease at the lower concen-
trations. This compares with a roughly 5-fold decrease in rate
across the same concentration range using inclusion body-puriﬁedmaterial [9], suggesting that contaminants in the inclusion body
preparation might have increased the aggregation of that protein.
(Note, however, that in all cases there is >95% recovery of input
material in the native form, consistent with any appreciable aggre-
gation being reversible.)
In contrast with these results in chloride-containing buffer,
when chloride was omitted from the buffer, we now observed an
increase in the rate of renaturation (for example, at 25 nM,
0.045 min1 in chloride buffer to 0.175 min1 in chloride-free buf-
fer; compare panels 1b and 1c). In addition, there was no apprecia-
ble concentration dependence to the refolding of DM-MBP in
chloride-free buffer (Fig. 1c). This agrees with the earlier conclu-
sion from the experiments with inclusion-body material that ab-
sence of chloride prevents aggregation. This conclusion was
directly supported here by light scattering measurements carried
out with 250 nM DM-MBP (or with 100 nM, not shown). In chlo-
ride-containing buffer, light scattering was observed immediately
upon dilution from denaturant, whereas in chloride-free buffer,
no signiﬁcant light scattering was observed (Fig. 1d). The absence
of light scattering in chloride-free buffer resembled the behavior
of wt-MBP (see Fig. 1d inset). Consistent with the effect of omission
of chloride to eliminate reversible off-pathway aggregation steps,
the rate of refolding of DM-MBP observed in the chloride-free con-
dition was virtually identical to the rate of GroEL–GroES–ATP-
dependent refolding of DM-MBP, 0.18 min1 (Fig. 1e). The chapero-
nin reaction was carried out here in the presence of chloride, but
the same rate constant is obtained for the chaperonin reaction in
chloride-free buffer (not shown).
Thus, these tests further demonstrate that DM-MBP, whether
inclusion body-puriﬁed or puriﬁed as a native protein, is subject
to reversible aggregation when attempting to refold in free solu-
tion, and this acts to slow the overall rate of recovery of the na-
tive state. Notably, such reversible aggregation, with attendant
kinetic effects, has been observed for a number of other proteins
(e.g., [11–13]). By contrast, and for reasons unknown, when
chloride is removed from the buffer, the aggregation of DM-
MBP is abolished (see the light scattering data in panel d), and
this brings the rate constant for refolding free in solution pre-
cisely to the rate of renaturation by the chaperonin system
(Fig. 1e), where a protein folds in an isolated chamber where
it cannot aggregate (see Fig. 13 in Ref. [14]). This supports the
conclusion that, at least in the case of DM-MBP, the chaperonin
system does not have an intrinsic ability to accelerate the rate of
folding of this encapsulated substrate. This suggests that the
folding chamber behaves essentially as an inﬁnite dilution cham-
ber. This has been directly supported in recent single molecule
FRET studies of Hofmann and coworkers with the substrate pro-
tein rhodanese, where its rate of recovery of the native state in
solution under inﬁnite dilution conditions was observed to be
the same as that inside the chaperonin chamber [15]. These
studies of DM-MBP and of rhodanese thus support that the
GroEL/GroES chamber serves principally as a passive chamber
that prevents aggregation, an ‘‘Anﬁnsen cage’’ [16].
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